Results 11 to 20 of about 189,595 (350)

Clinical study of anticoagulant therapy in patients with severe coronavirus disease: A single-center retrospective analysis

Vascular Investigation and Therapy, 2021
OBJECTIVE: The prognosis of COVID-19 is related to thrombotic events. This study investigated prognostic risk factors, anticoagulant therapy effects, and potential instruction of treatment or prognostic with D-dimer in patients with severe COVID-19 ...
Peng Zhou, Chuan-Qi Cai, Jin-Song Li, Huan-Zong Jiang, Zun-Xiang Ke, Shan Zhang, Zhong-Jian Wang, Chao Yang, Qin Li, Yi-Qing Li   +9 more
doaj   +1 more source

The year in cardiology: arrhythmias and pacing. [PDF]

, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H, Camm, AJ, Lip, GYH, Schilling, R, Steffel, J   +4 more
core   +4 more sources

Assessment of adherence level of patients on anticoagulant therapy in a tertiary healthcare facility in Uyo, Nigeria

Ibom Medical Journal, 2021
Background: Anticoagulants are highly effective in preventing venous thromboembolism and remains the main stay of treatment. However, strict adherence to medication is essential for maximizing treatment. Objectives: the objectives of this study, were to
Ekwere TA, Ekanem AM, Benson SM
doaj   +1 more source

Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study

Journal of Intensive Care, 2023
Background The development of disseminated intravascular coagulation (DIC) in patients with sepsis has been repeatedly confirmed as a factor associated with poor prognosis.
Takeshi Wada, Kazuma Yamakawa, Daijiro Kabata, Toshikazu Abe, Seitaro Fujishima, Shigeki Kushimoto, Toshihiko Mayumi, Hiroshi Ogura, Daizoh Saitoh, Atsushi Shiraishi, Yasuhiro Otomo, Satoshi Gando, the JAAM FORECAST Group   +12 more
doaj   +1 more source

Anticoagulation after typical atrial flutter ablation [PDF]

Клиническая практика, 2023
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial ...
Irina A. Bulavina, Igor A. Khamnagadaev, Igor I. Khamnagadaev, Mikhail L. Kokov, Aleksandr V. Troitskiy, Aleksandr S. Zotov, Leonid S. Kokov, Maria A. Shkolnikova   +7 more
doaj   +1 more source

Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)

Frontiers in Neurology, 2021
Objective: Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.Methods: This ...
Pål Rønning, Eirik Helseth, Eirik Helseth, Ola Skaansar, Cathrine Tverdal, Cathrine Tverdal, Nada Andelic, Nada Andelic, Rahul Bhatnagar, Mathias Melberg, Nils Oddvar Skaga, Mads Aarhus, Sigrun Halvorsen, Sigrun Halvorsen, Ragnhild Helseth   +14 more
doaj   +1 more source

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Mutiara Medika, 2022
Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis.
Agus Fitriyanto Achmad, Yuni Iswati Raharjani, Zidni Setyaningrum, Bagus Andi Pramono, Dita Ria Selvyana, Sri Pramesthi Wisnu Bowo Negoro   +5 more
doaj   +1 more source

Anticoagulant therapy in pediatrics [PDF]

Journal of Basic and Clinical Pharmacy, 2014
Thromboembolic episodes are disorders encountered in both children and adults, but relatively more common in adults. However, the occurrence of venous thromboembolism and use of anticoagulants in pediatrics are increasing. Unfractionated Heparin (UH) is used as a treatment and prevention of thrombosis in adults and critically ill children.
Mariam Dabbous, Fouad Sakr, Diana Malaeb
openaire   +3 more sources

Factors influencing primary care physicians’ prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study

BMC Family Practice, 2021
Background Oral anticoagulant therapy use in patients with atrial fibrillation (AF) remains suboptimal in Singapore, despite the availability of both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs).
Shera Chaterji, Lay Geok Lian, Ting Yee Lee, Liwei Chua, Sabrina Yi-Mei Wee, Sui Ling Yap, Dhana Letchimy K, Ngiap Chuan Tan   +7 more
doaj   +1 more source

Future of Anticoagulant Therapy [PDF]

Cardiovascular Therapeutics, 2010
Prophylaxis and treatment of thromboembolic diseases is one of the main targets in medicine. Side effects and the necessity of dose adjustment limit the administration of coumarins and unfractionated heparin. Coumarins are therefore underused specially in the elderly population. Low-molecular-weight heparins, heparinoids, and direct thrombin inhibitors
Job Harenberg, Martin Wehling
openaire   +3 more sources